We are live on ! Find out more
GALT icon

Galectin Therapeutics
GALT

75 hedge funds and large institutions have $31.1M invested in Galectin Therapeutics in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $19M → $31.1M (+$12.1M)

62% more call options, than puts

Call options by funds: $442K | Put options by funds: $273K

41% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 17

0.84% more ownership

Funds ownership: 16.98% → 17.82% (+0.84%)

3% less funds holding

Funds holding: 77 → 75 (-2)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
24
Reduced
17
Closed
9
Calls
$442K
Puts
$273K
Net Calls
+$169K
Net Calls Change
+$56K

Top Buyers

Rank Fund Capital Flow
1
CCB
Cutter & Co Brokerage
Missouri
+$465K
2
Osaic Holdings
Osaic Holdings
Arizona
+$373K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$198K
4
Two Sigma Investments
Two Sigma Investments
New York
+$149K
5
N
Nuveen
North Carolina
+$131K

Top Sellers

Rank Fund Capital Flow
1
BWM
BT Wealth Management
Georgia
-$118K
2
BlackRock
BlackRock
New York
-$98.5K
3
Citadel Advisors
Citadel Advisors
Florida
-$91.1K
4
Northern Trust
Northern Trust
Illinois
-$57.1K
5
HS
HighVista Strategies
Massachusetts
-$50K
Name Holding Trade Value Shares
Change 		Change in
Stake
IWM
26
IHT Wealth Management
Illinois
$86K +$25.2K +10,000 +55%
JP Morgan Chase
27
JP Morgan Chase
New York
$85K -$31.7K -12,588 -31%
RJA
28
Raymond James & Associates
Florida
$85K – – –
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$74K – – –
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$72K – – –
AIG
31
American International Group
New York
$70K -$2.43K -966 -4%
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$66K -$21.5K -8,552 -28%
Goldman Sachs
33
Goldman Sachs
New York
$64K +$10.4K +4,119 +25%
Barclays
34
Barclays
United Kingdom
$64K +$19.3K +7,669 +57%
WS
35
Wedbush Securities
California
$63K – – –
SG Americas Securities
36
SG Americas Securities
New York
$62K +$19K +7,542 +59%
Ameriprise
37
Ameriprise
Minnesota
$62K +$50.8K +20,199 New
Deutsche Bank
38
Deutsche Bank
Germany
$56K +$11.5K +4,582 +33%
IGGA
39
Iron Gate Global Advisors
Utah
$52K – – –
CAN
40
Cetera Advisor Networks
California
$50K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$49K +$40K +15,900 New
CF
42
Centaurus Financial
California
$48K +$1.04K +413 +3%
Citadel Advisors
43
Citadel Advisors
Florida
$47K -$91.1K -36,220 -70%
VOYA Investment Management
44
VOYA Investment Management
Georgia
$42K -$23.5K -9,355 -41%
WANY
45
Wealthspire Advisors (New York)
New York
$42K – – –
Wolverine Trading
46
Wolverine Trading
Illinois
$41K +$33.7K +13,376 New
VCM
47
Vivaldi Capital Management
Illinois
$40K +$12K +4,771 +45%
PPA
48
Parametric Portfolio Associates
Washington
$40K +$32.7K +13,004 New
UBS Group
49
UBS Group
Switzerland
$38K -$31.7K -12,608 -50%
SKK
50
Shepherd Kaplan Krochuk
Massachusetts
$37K +$30.2K +12,000 New
1
2
3 4

GALT Hedge Fund Activity: Q2 2020 in Review

75 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Galectin Therapeutics (GALT) for Q2 2020, worth a combined $31.1M — up 64% from $19M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GALT and 8 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 24 added.

The largest buyer was Cutter & Co Brokerage, opening a new position worth an estimated $465K. The largest seller was BT Wealth Management, exiting entirely with an estimated $118K sold.

  • 75 institutional investors held Galectin Therapeutics (GALT) as of Q2 2020, down from 77 in Q1 2020.
  • Funds reported $31.1M of Galectin Therapeutics stock for Q2 2020, up 64% quarter-over-quarter.
  • 8 funds opened new Galectin Therapeutics positions in Q2 2020 and 9 closed out, a net change of -1 holder.
  • The largest Galectin Therapeutics buyer in Q2 2020 was Cutter & Co Brokerage, an estimated $465K added.
  • The largest Galectin Therapeutics seller in Q2 2020 was BT Wealth Management, an estimated $118K sold.

Based on aggregated 13F filings for Q2 2020.